Revolution Medicines, Inc.
RVMD
$149.94
$4.222.90%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.37B | -1.13B | -960.98M | -812.06M | -697.51M |
| Total Depreciation and Amortization | 16.78M | 15.66M | 14.14M | 12.68M | 11.68M |
| Total Amortization of Deferred Charges | 600.00K | 900.00K | 1.10M | 1.10M | 1.10M |
| Total Other Non-Cash Items | 229.41M | 130.18M | 87.35M | 62.88M | 43.36M |
| Change in Net Operating Assets | 67.44M | 86.82M | 96.60M | 50.49M | 50.06M |
| Cash from Operations | -1.06B | -897.74M | -761.79M | -684.90M | -591.31M |
| Capital Expenditure | -14.26M | -15.99M | -15.29M | -15.46M | -10.41M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 320.88M | 134.05M | -334.44M | -380.59M | -311.97M |
| Cash from Investing | 306.62M | 118.06M | -349.73M | -396.05M | -322.38M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 615.19M | 377.09M | 789.72M | 862.87M | 863.79M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 244.20M | 244.44M | 339.95M | 345.69M | 95.69M |
| Cash from Financing | 859.39M | 621.52M | 1.13B | 1.21B | 959.48M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 108.55M | -158.16M | 18.15M | 127.61M | 45.79M |